O-GlcNAc modification of PPARγ reduces its transcriptional activity

被引:63
|
作者
Ji, Suena [2 ]
Park, Sang Yoon [2 ]
Roth, Juergen [3 ]
Kim, Hoe Suk [1 ]
Cho, Jin Won [2 ,3 ]
机构
[1] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul 110744, South Korea
[2] Yonsei Univ, Dept Biol, Seoul 120749, South Korea
[3] Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea
基金
新加坡国家研究基金会;
关键词
O-GlcNAc; PPAR gamma; Adipogenesis; 3T3-L1; ACTIVATED RECEPTOR-GAMMA; N-ACETYLGLUCOSAMINE; C/EBP-ALPHA; INSULIN-RESISTANCE; MASS-SPECTROMETRY; GENE PROMOTER; ADIPOGENESIS; BETA; EXPRESSION; GLCNACYLATION;
D O I
10.1016/j.bbrc.2011.12.086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peroxisome proliferator-activated receptor gamma (PPAR gamma), a member of the nuclear receptor superfamily, is a key regulator of adipogenesis and is important for the homeostasis of the adipose tissue. The beta-O-linked N-acetylglucosamine (O-GlcNAc) modification, a posttranslational modification on various nuclear and cytoplasmic proteins, is involved in the regulation of protein function. Here, we report that PPAR gamma is modified by O-GIcNAc in 3T3-L1 adipocytes. Mass spectrometric analysis and mutant studies revealed that the threonine 54 of the N-terminal AF-1 domain of PPAR gamma is the major O-GlcNAc site. Transcriptional activity of wild type PPAR gamma was decreased 30% by treatment with the specific O-GlcNAcase (OGA) inhibitor, but the T54A mutant of PPAR gamma did not respond to inhibitor treatment. In 3T3-L1 cells, an increase in O-GlcNAc modification by OGA inhibitor reduced PPAR gamma transcriptional activity and terminal adipocyte differentiation. Our results suggest that the O-GlcNAc state of PPAR gamma influences its transcriptional activity and is involved in adipocyte differentiation. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1158 / 1163
页数:6
相关论文
共 50 条
  • [41] O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity
    Issad, Tarik
    Kuo, MeiShiue
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (10): : 380 - 389
  • [42] O-GlcNAc modification: why so intimately associated with phosphorylation?
    Suresh Mishra
    Sudharsana R Ande
    Neil W Salter
    Cell Communication and Signaling, 9
  • [43] O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy
    Dong, Wenkang
    Imdad, Laraib
    Xu, Shengnan
    Wang, Yinli
    Liu, Chengzhi
    Song, Shiyu
    Li, Zechuan
    Kong, Ying
    Kong, Li
    Ren, Xiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [44] Combining HCD and ETD to Determine Sites of O-Glcnac Modification
    Zhao, Peng
    Viner, Rosa
    Teo, Chin Fen
    Brimble, Sandii
    Horn, David M.
    Wells, Lance
    GLYCOBIOLOGY, 2010, 20 (11) : 1470 - 1470
  • [45] O-GlcNAc in the dark
    Angeliki Chalkiadaki
    Nature Chemical Biology, 2012, 8 (4) : 320 - 320
  • [46] Mapping the sites of O-GlcNAc modification of IRS-1
    Ball, LE
    Berkaw, MN
    Robinson, KA
    Buse, MG
    DIABETES, 2005, 54 : A624 - A624
  • [47] O-GlcNAc modification alters α-synuclein aggregation and neuronal toxicity
    Galesic, Ana
    Levine, Paul
    Balana, Aaron John
    Pratt, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [48] O-GlcNAc modification: why so intimately associated with phosphorylation?
    Mishra, Suresh
    Ande, Sudharsana R.
    Salter, Neil W.
    CELL COMMUNICATION AND SIGNALING, 2011, 9
  • [49] Functional significance of O-GlcNAc modification in regulating neuronal properties
    Hwang, Hongik
    Rhim, Hyewhon
    PHARMACOLOGICAL RESEARCH, 2018, 129 : 295 - 307
  • [50] O-GlcNAc modification is essential for the regulation of autophagy in Drosophila melanogaster
    Sujin Park
    Yangsin Lee
    Jin Won Pak
    Hanbyeol Kim
    Hyeonjin Choi
    Jae-woo Kim
    Jürgen Roth
    Jin Won Cho
    Cellular and Molecular Life Sciences, 2015, 72 : 3173 - 3183